PE20000467A1 - Derivado de indol util como inhibidor de serotonina - Google Patents
Derivado de indol util como inhibidor de serotoninaInfo
- Publication number
- PE20000467A1 PE20000467A1 PE1999000381A PE00038199A PE20000467A1 PE 20000467 A1 PE20000467 A1 PE 20000467A1 PE 1999000381 A PE1999000381 A PE 1999000381A PE 00038199 A PE00038199 A PE 00038199A PE 20000467 A1 PE20000467 A1 PE 20000467A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- indole derivative
- derivative useful
- serotonin inhibitor
- alcoxy
- Prior art date
Links
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 229940076279 serotonin Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 abstract 1
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 230000000862 serotonergic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Otolaryngology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE n ES 1-6; m ES 1-2; p ES 1-2; R1 Y R2 SON H, ALQUILO C1-C4, ALCOXI C1-C4, OH-ALQUILO C1-C4, HALO, FENILO OPCIONALMENTE SUSTITUIDO, FENIL-ALQUILO C1-C4, ENTRE OTROS; O R1 Y R2 FORMAN UN CICLOALQUILO C3-C6, >C=O, C=NOR`; R' ES H, ALQUILO C1-C4; R3, R4 Y R5 SON H, HALO, NITRO, ALQUILO C1-C4, ALCOXI C1-C4, CO-ALQUILO C1-C4, R'R''N-SO2-, -COOR', -CONR'R'', -NR'R'', ENTRE OTROS; R' Y R'' SON H, ALQUILO C1-C4; R6 Y R7 SON H, ALQUILO C1-C4; X ES O, S; EL FLUOR ESTA UNIDO EN LAS POSICIONES 6 o 7. EL COMPUESTO I TIENE AFINIDAD SELECTIVA PARA LOS RECEPTORES DE 5HT SIENDO UN MODULADOR SEROTONERGICO UTIL PARA EL TRATAMIENTO DE TRASTORNOS DEL SISTEMA NERVIOSO CENTRAL
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9810886.3A GB9810886D0 (en) | 1998-05-13 | 1998-05-13 | Pharmaceutical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20000467A1 true PE20000467A1 (es) | 2000-06-05 |
Family
ID=10832426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000381A PE20000467A1 (es) | 1998-05-13 | 1999-05-10 | Derivado de indol util como inhibidor de serotonina |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6166040A (es) |
| EP (1) | EP0963983A1 (es) |
| JP (1) | JP2002514642A (es) |
| AR (1) | AR018859A1 (es) |
| AU (1) | AU3838499A (es) |
| CA (1) | CA2330796A1 (es) |
| CO (1) | CO5031250A1 (es) |
| GB (1) | GB9810886D0 (es) |
| PE (1) | PE20000467A1 (es) |
| SV (1) | SV1999000059A (es) |
| WO (1) | WO1999058525A1 (es) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9825413D0 (en) | 1998-11-19 | 1999-01-13 | Lilly Co Eli | Pharmaceutical compounds |
| US6844338B2 (en) | 2000-05-18 | 2005-01-18 | Eli Lilly And Company | Piperidyindoles as serotonin receptor ligands |
| GB2362381A (en) * | 2000-05-18 | 2001-11-21 | Lilly Co Eli | Pharmaceutically active indolyl-piperidines |
| AR028685A1 (es) * | 2000-06-14 | 2003-05-21 | Lundbeck & Co As H | Derivados de indol |
| DK1294710T3 (da) * | 2000-06-14 | 2005-10-03 | Lundbeck & Co As H | Indolderivater, der er egnede til behandlingen af CNS-lidelser |
| GB2370270A (en) * | 2000-12-20 | 2002-06-26 | Lilly Co Eli | Pharmaceutical compounds |
| DK1392697T3 (da) * | 2001-03-14 | 2005-02-14 | Wyeth Corp | Antidepressive azaheterocyclylmethylderivater af 2,3-dihydro-1,4-dioxino[2.3-f]quinolin |
| SK12012003A3 (en) | 2001-03-29 | 2004-10-05 | Bristol Myers Squibb Co | Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| US6861434B2 (en) * | 2001-04-26 | 2005-03-01 | Wyeth | Antipsychotic aminomethyl derivatives of 1,3,7,8-tetrahydro-6,9-dioxa-1,3-diaza-cyclopenta[a]-naphthalen-2-one |
| US6555560B2 (en) * | 2001-04-30 | 2003-04-29 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene |
| US6906206B2 (en) | 2001-04-30 | 2005-06-14 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of 1,4,5-trioxa-phenanthrene |
| CN100352820C (zh) * | 2002-09-12 | 2007-12-05 | 惠氏公司 | 抗抑郁的杂环稠合的苯并二噁烷的氮杂环甲基衍生物 |
| US7135479B2 (en) | 2002-09-12 | 2006-11-14 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans |
| DE10337184A1 (de) | 2003-08-13 | 2005-03-10 | Gruenenthal Gmbh | Substituierte 3-Pyrrolidin-Indol-Derivate |
| US7786141B2 (en) | 2004-08-19 | 2010-08-31 | Vertex Pharmaceuticals Incorporated | Dihydrospiroindene modulators of muscarinic receptors |
| MX2007002033A (es) * | 2004-08-19 | 2007-04-26 | Vertex Pharma | Moduladores de receptores muscarinicos. |
| EP1817036B1 (en) * | 2004-11-29 | 2012-07-04 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| RU2008130094A (ru) * | 2005-12-22 | 2010-01-27 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | Модуляторы мускариновых рецепторов |
| KR20080094964A (ko) * | 2006-02-22 | 2008-10-27 | 버텍스 파마슈티칼스 인코포레이티드 | 무스카린성 수용체의 조절제 |
| KR20080098070A (ko) * | 2006-02-22 | 2008-11-06 | 버텍스 파마슈티칼스 인코포레이티드 | 무스카린성 수용체의 조절제로서의 스피로 축합된 피페리딘 |
| CA2656183A1 (en) * | 2006-06-29 | 2008-01-10 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| CA2660903A1 (en) * | 2006-08-15 | 2008-02-21 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| WO2008021545A2 (en) * | 2006-08-18 | 2008-02-21 | Vertex Pharmaceuticals Incorporated | Modulators of muscarinic receptors |
| JP2010540640A (ja) * | 2007-10-03 | 2010-12-24 | バーテックス ファーマシューティカルズ インコーポレイテッド | ムスカリン作用性レセプターのモジュレーター |
| KR20230117597A (ko) * | 2020-12-07 | 2023-08-08 | 마인드셋 파마 인크. | Cns 장애의 치료를 위한 세로토닌성 작용제로서의 3-시클릭아민-인돌 유도체 |
| KR102509625B1 (ko) * | 2022-03-25 | 2023-03-14 | 주식회사 메드팩토 | TGF-β 저해제의 합성에 유용한 중간체 및 이를 이용한 TGF-β 저해제 제조방법 |
| WO2025021120A1 (zh) * | 2023-07-24 | 2025-01-30 | 上海翊石医药科技有限公司 | 一类5-ht2a受体激动剂及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3981881A (en) * | 1975-08-14 | 1976-09-21 | E. R. Squibb & Sons, Inc. | 2-[(4-Phenyl-tetrahydropyridinyl)alkyl]-1H-isoindole-1,3(2H)-diones |
| JP2860688B2 (ja) * | 1990-03-14 | 1999-02-24 | 第一製薬株式会社 | インドール誘導体 |
| FR2675801A1 (fr) * | 1991-04-24 | 1992-10-30 | Rhone Poulenc Rorer Sa | Piperidines, leur preparation et les medicaments les contenant. |
| SE9103752D0 (sv) * | 1991-12-18 | 1991-12-18 | Astra Ab | New compounds |
| US5521196A (en) * | 1994-10-05 | 1996-05-28 | Eli Lilly And Company | 5-HT1F agonists for the treatment of migraine |
| TW421649B (en) * | 1995-01-31 | 2001-02-11 | Janssen Pharmaceutica Nv | 4-(1H-indol-1yl)-1-piperidinyl derivatives |
| GB2308362A (en) * | 1995-12-19 | 1997-06-25 | Lilly Industries Ltd | Pharmaceutical indole derivatives |
-
1998
- 1998-05-13 GB GBGB9810886.3A patent/GB9810886D0/en not_active Ceased
-
1999
- 1999-05-10 PE PE1999000381A patent/PE20000467A1/es not_active Application Discontinuation
- 1999-05-11 JP JP2000548329A patent/JP2002514642A/ja active Pending
- 1999-05-11 CO CO99029124A patent/CO5031250A1/es unknown
- 1999-05-11 EP EP99303663A patent/EP0963983A1/en not_active Withdrawn
- 1999-05-11 US US09/309,420 patent/US6166040A/en not_active Expired - Fee Related
- 1999-05-11 SV SV1999000059A patent/SV1999000059A/es unknown
- 1999-05-11 AR ARP990102204A patent/AR018859A1/es unknown
- 1999-05-11 WO PCT/GB1999/001474 patent/WO1999058525A1/en not_active Ceased
- 1999-05-11 AU AU38384/99A patent/AU3838499A/en not_active Abandoned
- 1999-05-11 CA CA002330796A patent/CA2330796A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| SV1999000059A (es) | 2000-07-04 |
| US6166040A (en) | 2000-12-26 |
| JP2002514642A (ja) | 2002-05-21 |
| CO5031250A1 (es) | 2001-04-27 |
| AU3838499A (en) | 1999-11-29 |
| AR018859A1 (es) | 2001-12-12 |
| WO1999058525A1 (en) | 1999-11-18 |
| EP0963983A1 (en) | 1999-12-15 |
| CA2330796A1 (en) | 1999-11-18 |
| GB9810886D0 (en) | 1998-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20000467A1 (es) | Derivado de indol util como inhibidor de serotonina | |
| PE20250114A1 (es) | Compuestos indol sustituidos y metodos de uso de los mismos | |
| CO4440628A1 (es) | Derivados de pirimidina condensados con un anillo heteroci- clico | |
| PE20020692A1 (es) | Compuestos derivados de benzotiofeno y su procedimiento de obtencion | |
| ES2127946T3 (es) | Antagonistas de neurocinina diazabiciclica. | |
| ES2164758T3 (es) | Derivados de morfolina sustituidos y su uso como agentes terapeuticos. | |
| PE20080010A1 (es) | Derivados de diazepina para el tratamiento de la depresion y composiciones farmaceuticas que los comprenden | |
| PE20020720A1 (es) | Derivados benzimidazol y piridilimidazol como ligandos para receptores gabaa | |
| ES2164657T3 (es) | Derivados aza-biciclicos puenteados como antagonistas de la sustancia p. | |
| DK0923542T3 (da) | Arylsubstituerede cycliske aminer som selektive dopamin-D3-ligander | |
| PE20030292A1 (es) | Compuestos de heteroarilo biciclicos fusionados substituidos con heteroarilo como ligandos del receptor gabaa | |
| SV2002000022A (es) | Inhibidores de recanalizacion de la monoamida para el tratamiento de los desordenes del sistema nervioso central ref. pc10434 | |
| CR6616A (es) | Nuevos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas | |
| PE20020510A1 (es) | DERIVADOS DE AZEPILO [4,5b] INDOLINA SUSTITUIDOS COMO LIGANDOS DE LOS RECEPTORES DE SEROTONINA (5-HT) | |
| PE20060555A1 (es) | Derivados de pirrol-oxindol como moduladores del receptor de progesterona | |
| ECSP045379A (es) | Derivados de [1,4]diazepino[6,7,1-ij]quinolina como agentes antipsicóticos y contra la obesidad | |
| PE20030471A1 (es) | Compuesto de imidazopiridin como moduladores del receptor 5-ht4 | |
| ES2031513T3 (es) | Quinazolindionas y piridopirimidinadionas. | |
| CO5150159A1 (es) | Derivados de 4-arilquinolin-2-ona 3-substituida como moduladores de los canales de potasio | |
| DK0465398T3 (da) | Indolforbindelser | |
| ES2113368T3 (es) | Antagonistas de serotonina. | |
| ES2173846T3 (es) | Compuestos de biciclocarbonil indol como agentes antiinflamatorios/analgesicos y como inhibidores de cox-2. | |
| PE20001543A1 (es) | Derivados de piridopiranoacepinas, su preparacion y su aplicacion en terapeutica | |
| ES2084339T3 (es) | Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central. | |
| PE20080126A1 (es) | Metodos para tratar trastornos cognitivos y otros afines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |